2023 Senate Bill 542

Health: pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow.

A bill to prescribe the types of opioid antagonists distributed to certain persons or governmental entities in this state; and to provide for the powers and duties of certain state officers and entities.

Senate Fiscal Agency Analysis

The bill would enact a new law to allow a person or governmental entity that was distributed an opioid antagonist by the Department of Health and Human Services (DHHS) at no cost to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist that the person or agency received; however, the bill specifies that the ability to choose the formulation or dosage of an opioid antagonist would not apply if that formulation or dosage choice jeopardized the DHHS's receipt of Federal funding.

Introduced in the Senate

Oct. 3, 2023

Introduced by Sen. Kevin Hertel (D-12) and 9 co-sponsors

Co-sponsored by Sens. Erika Geiss (D-1), Rosemary Bayer (D-13), Sue Shink (D-14), Paul Wojno (D-10), Sean McCann (D-19), Joseph Bellino (R-16), Stephanie Chang (D-3), Mark Huizenga (R-30) and Darrin Camilleri (D-4)

Referred to the Committee on Health Policy

Oct. 2, 2024

Reported without amendment

Oct. 8, 2024

Referred to the Committee of the Whole

Oct. 23, 2024

Reported without amendment

Passed in the Senate 38 to 0 (details)

Received in the House

Nov. 7, 2024

Referred to the Committee on Health Policy

Dec. 12, 2024

Reported without amendment